These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19729205)

  • 1. Objectively measured motor activity in schizophrenia challenges the validity of expert ratings.
    Walther S; Koschorke P; Horn H; Strik W
    Psychiatry Res; 2009 Oct; 169(3):187-90. PubMed ID: 19729205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative motor activity differentiates schizophrenia subtypes.
    Walther S; Horn H; Razavi N; Koschorke P; Müller TJ; Strik W
    Neuropsychobiology; 2009; 60(2):80-6. PubMed ID: 19752582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of objectively measured motor behavior with ratings of the motor behavior domain of the Bern Psychopathology Scale (BPS) in schizophrenia.
    Bracht T; Heidemeyer K; Koschorke P; Horn H; Razavi N; Wopfner A; Strik W; Walther S
    Psychiatry Res; 2012 Jul; 198(2):224-9. PubMed ID: 22406395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new rating scale for negative symptoms: the Motor-Affective-Social Scale.
    Trémeau F; Goggin M; Antonius D; Czobor P; Hill V; Citrome L
    Psychiatry Res; 2008 Sep; 160(3):346-55. PubMed ID: 18722021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxidative mechanisms in schizophrenia and their relationship with illness subtype and symptom profile.
    Pazvantoglu O; Selek S; Okay IT; Sengul C; Karabekiroglu K; Dilbaz N; Erel O
    Psychiatry Clin Neurosci; 2009 Oct; 63(5):693-700. PubMed ID: 19788631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measuring motor activity in major depression: the association between the Hamilton Depression Rating Scale and actigraphy.
    Razavi N; Horn H; Koschorke P; Hügli S; Höfle O; Müller T; Strik W; Walther S
    Psychiatry Res; 2011 Dec; 190(2-3):212-6. PubMed ID: 21663976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Core factors of schizophrenia structure based on PANSS and SAPS/SANS results. Discerning and head-to-head comparisson of PANSS and SASPS/SANS validity].
    Masiak M; Loza B
    Psychiatr Pol; 2004; 38(5):795-808. PubMed ID: 15523927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theory of mind in schizophrenia: the role of clinical symptomatology and neurocognition in understanding other people's thoughts and intentions.
    Abdel-Hamid M; Lehmkämper C; Sonntag C; Juckel G; Daum I; Brüne M
    Psychiatry Res; 2009 Jan; 165(1-2):19-26. PubMed ID: 19073346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurological soft signs in schizophrenic patients and their nonaffected siblings].
    Mechri A; Slama H; Bourdel MC; Chebel S; Mandhouj O; Krebs MO; Gaha L
    Encephale; 2008 Oct; 34(5):483-9. PubMed ID: 19068337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are ratings on the positive and negative syndrome scale for schizophrenia biased by personality traits?
    Huber CG; Hoppe A; Agorastos A; Andresen B; Naber D; Schroeder K
    Pharmacopsychiatry; 2012 Jun; 45(4):156-61. PubMed ID: 22290202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycine serum level in schizophrenia: relation to negative symptoms.
    Hons J; Zirko R; Ulrychova M; Cermakova E; Doubek P; Libiger J
    Psychiatry Res; 2010 Apr; 176(2-3):103-8. PubMed ID: 20096465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How specific are negative symptoms and cognitive impairment in schizophrenia? An analysis of PANSS and SCoRS.
    Cruz BF; de Resende CB; Abreu MN; Rocha FL; Teixeira AL; Keefe RS; Salgado JV
    Cogn Neuropsychiatry; 2013 May; 18(3):243-51. PubMed ID: 23145794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Video-based quantification of body movement during social interaction indicates the severity of negative symptoms in patients with schizophrenia.
    Kupper Z; Ramseyer F; Hoffmann H; Kalbermatten S; Tschacher W
    Schizophr Res; 2010 Aug; 121(1-3):90-100. PubMed ID: 20434313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of switching to long-acting injectable risperidone from oral atypical antipsychotics on cognitive function in patients with schizophrenia.
    Kim SW; Shin IS; Kim JM; Lee SH; Lee YH; Yang SJ; Yoon JS
    Hum Psychopharmacol; 2009 Oct; 24(7):565-73. PubMed ID: 19790174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Thai version of the Positive and Negative Syndrome Scale (PANSS) for schizophrenia: criterion validity and interrater reliability.
    Nilchaikovit T; Uneanong S; Kessawai D; Thomyangkoon P
    J Med Assoc Thai; 2000 Jun; 83(6):646-51. PubMed ID: 10932491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Actigraphic measurement of motor deficits in acute ischemic stroke.
    Gebruers N; Truijen S; Engelborghs S; Nagels G; Brouns R; De Deyn PP
    Cerebrovasc Dis; 2008; 26(5):533-40. PubMed ID: 18836264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Three-dimensional ultrasonic movement analysis of gait and hand-movements in schizophrenic patients].
    Putzhammer A; Perfahl M; Pfeiff L; Müller JL
    Psychiatr Prax; 2005 Apr; 32 Suppl 1():S38-42. PubMed ID: 15818519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of social anxiety from virtual interpersonal interactions in patients with schizophrenia.
    Park IH; Kim JJ; Ku J; Jang HJ; Park SH; Kim CH; Kim IY; Kim SI
    Psychiatry; 2009; 72(1):79-93. PubMed ID: 19366296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between changes on the Negative Symptom Assessment scale (NSA-16) and measures of functional outcome in schizophrenia.
    Velligan DI; Alphs L; Lancaster S; Morlock R; Mintz J
    Psychiatry Res; 2009 Sep; 169(2):97-100. PubMed ID: 19664826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Schizophrenia with prominent catatonic features ('catatonic schizophrenia') III. Latent class analysis of the catatonic syndrome.
    Ungvari GS; Goggins W; Leung SK; Lee E; Gerevich J
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):81-5. PubMed ID: 18992297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.